Physician profile
Don A Buford
NPI 1720089899
$80,485.07
in general payments reported to CMS, 2019-2025
23 companies · $4,231 in 2025
The $4,231 reported for 2025 was more than what 79% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,911 · 2020: $2,262 · 2021: $4,458 · 2022: $19K · 2023: $37K · 2024: $6,172 · 2025: $4,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Royalty Or License: $6,000 · Travel and Lodging: $4,138 · Food and Beverage: $3,570 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,250.00 |
| Royalty Or License | $6,000.00 |
| Travel and Lodging | $4,137.53 |
| Food and Beverage | $3,569.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $36,672.90 | 2019-2024 | Biobrace 23mm, Knee Biologics, Allograft Tissue |
| Trice Medical, INC. | $23,034.42 | 2019-2025 | |
| Globus Medical, INC. | $12,422.81 | 2022 | |
| Ranfac Corporation | $3,427.28 | 2025 | |
| Bioventus LLC | $1,420.91 | 2021-2023 | Durolane |
| Pacira Therapeutics, INC. | $700.00 | 2019 | |
| Pylant Medical | $612.14 | 2021-2023 | |
| Arcuro Medical INC | $500.00 | 2022 | |
| Tenex Health INC. | $287.90 | 2021 | |
| Arthrex, INC. | $238.34 | 2023-2024 | Arthrex |
| Konica Minolta Healthcare Americas, INC | $160.36 | 2019 | |
| Horizon Therapeutics Plc | $145.95 | 2019-2021 | |
| Spinesmith Holdings, LLC | $121.99 | 2019 | |
| Cpm Medical Consultants, LLC | $121.65 | 2020 | |
| Baxter Healthcare | $121.31 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $119.80 | 2023 | Te X, Te7 Max |
| Anika Therapeutics, INC. | $103.95 | 2020 | |
| Depuy Synthes Sales INC. | $73.56 | 2021-2023 | Monovisc, Orthovisc |
| Vertex Pharmaceuticals Incorporated | $64.31 | 2025 | |
| Orthofix Medical, INC. | $42.26 | 2023-2025 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $37.00 | 2021-2023 | |
| Heraeus Medical, LLC. | $31.27 | 2021 | |
| Innovation Technologies INC | $24.96 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,223.10 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Buford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.